|
|
Crystalgenomics Incorporation - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for Crystalgenomics Incorporation. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
Crystalgenomics Incorporation. The Group's principal activity is providing biotechnology services. The Company has two main businesses: new drug development and structure determination research. Its new drug development business is involved in the development of anti-cancer remedies, antibiotics, remedies for glycosuria and hypoxia diseases, and obesity treatment medicines. Its structure determination research business mainly provides three dimensional structure determination services.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|